Skip to content

Further Studies in the Therapeutic Value of Lysergic Acid Diethylamide in Mental Illness

R. A. Sandison, J. D. A. Whitelaw

Journal of Mental Science April 1, 1957 DOI: 10.1192/bjp.103.431.332 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Case series Case report Peer reviewed
Population Patients with mental illness
Intervention Lysergic acid diethylamide
Topics LSD
Citations 80
Key findings LSD shows potential as a therapeutic tool for mental illness, with observed benefits in some patients when administered carefully.

Abstract

This paper follows a preliminary communication to this Journal two years ago (Sandison, Spencer and Whitelaw, 1954) and gives an account of the fuller experience gained up to the present time with lysergic acid diethylamide in the treatment of mental illness.

Comparable studies

Other case reports and case series on LSD, most cited first.

Study Year Design Participants
Lasting Neuropsychiatric Sequelae of (??)Methylenedioxymethamphetamine (???Ecstasy???) in Recreational Users Persons who ingested large doses of MDMA 1991 Case study n = 2
Coma, Hyperthermia, and Bleeding Associated with Massive LSD Overdose a Report of Eight Cases People who self-administered large amounts of pure LSD powder intranasally 1975 Case series n = 8
Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders Patients with chronic complex post-traumatic stress disorder (c-PTSD), dissociative,... 2022 Case series
Persistent Palinopsia Following Ingestion of Lysergic Acid Diethylamide (LSD) Patients who developed persistent palinopsia after LSD ingestion 1996 Case series n = 3
The dangers of LSD. Analysis of seven months' experience in a university hospital's psychiatric service Patients with adverse reactions to LSD taken outside medical or research settings 1966 Case series n = 70

Citations in the library

Explore topics